Cargando…
Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
Autores principales: | He, Cai, He, Xuemei, Yang, Jingyun, Lei, Hong, Hong, Weiqi, Song, Xiangrong, Yang, Li, Li, Jiong, Wang, Wei, Shen, Guobo, Lu, Guangwen, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994023/ https://www.ncbi.nlm.nih.gov/pubmed/35397623 http://dx.doi.org/10.1038/s41392-022-00980-6 |
Ejemplares similares
-
A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
por: He, Cai, et al.
Publicado: (2023) -
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
por: He, Cai, et al.
Publicado: (2023) -
A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
por: He, Cai, et al.
Publicado: (2021) -
SARS-CoV-2 (B1.1.529) Omicron variant: what has changed in the nose?
por: Ciurkiewicz, M., et al.
Publicado: (2023)